TELA Bio (TELA) Gains from Sales and Divestitures (2024 - 2026)
TELA Bio's Gains from Sales and Divestitures came in at -$18,000 for Q1 2026.
Powered by 
Analysis
TELA Bio (TELA) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
For FY2024, TELA Bio's Gains from Sales and Divestitures was $7.58 million.
- Going back by year, Gains from Sales and Divestitures was $12,000 in FY2023 and -$2,000 in FY2021.
- The Q1 2026 figure represents the highest quarterly Gains from Sales and Divestitures since Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn |
| 10 | TELA Bio | 65.45 Mn | -85.07 Mn | 13.94 Mn |
API Access
TELA Bio Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TELA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "TELA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TELA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();